Clinical trials
Phase 2/3 Pulmonary Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 1 |
| Alicia Gerke | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Daniels, Craig E., M.D. | 1 |
| Grupo Medifarma, S. A. de C. V. | 1 |
| Guangzhou JOYO Pharma Co., Ltd | 1 |
| Interstitial Lung Disease Study Group, Korea | 1 |
| PHARMENTERPRISES LLC | 1 |
| Royal Brompton & Harefield NHS Foundation Trust | 1 |
| Tokyo University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 11 |
| Idiopathic Pulmonary Fibrosis | 3 |
| Scleroderma, Diffuse | 3 |
| Scleroderma, Systemic | 3 |
| Lung Diseases | 2 |
| Lung Diseases, Interstitial | 2 |
| Respiratory Tract Diseases | 2 |
| Alveolitis, Extrinsic Allergic | 1 |
| Arthritis | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.